After Power Grid, China Hackers Also Targeted Indian Vaccine Makers for 'Competitive Advantage': Report
News 18A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose coronavirus shots are being used in the country’s immunisation campaign, cyber intelligence firm Cyfirma told Reuters. Goldman Sachs-backed Cyfirma, based in Singapore and Tokyo, said Chinese hacking group APT10, also known as Stone Panda, had identified gaps and vulnerabilities in the IT infrastructure and supply chain software of Bharat Biotech and the Serum Institute of India, the world’s largest vaccine maker. “The real motivation here is actually exfiltrating intellectual property and getting competitive advantage over Indian pharmaceutical companies,” said Cyfirma Chief Executive Kumar Ritesh, formerly a top cyber official with British foreign intelligence agency MI6. A new study has also revealed that computer networks of at least 12 Indian state-run organisations, primarily power utilities and load dispatch centres, have been targeted by Chinese state- Ritesh said APT10 was actively targeting SII, which is making the AstraZeneca vaccine for many countries and will soon start bulk-manufacturing Novavax shots.